ClinVar Miner

Variants studied for Epstein-Barr virus-associated carcinoma

Included ClinVar conditions (6):
Minimum submission review status: Collection method:
Minimum conflict level:
Gene type:

If a variant has more than one submission, it may be counted in more than one significance column. If this is the case, the total number of variants will be less than the sum of the other cells.

pathogenic likely pathogenic uncertain significance likely benign benign total
19 16 20 6 3 64

Gene and significance breakdown #

Total genes and gene combinations: 10
Download table as spreadsheet
Gene or gene combination pathogenic likely pathogenic uncertain significance likely benign benign total
TP53 15 9 19 5 2 50
KMT2D 1 2 0 0 0 3
MST1R 1 0 1 1 0 3
SMARCA4 0 2 0 0 0 2
BRAF 0 1 0 0 0 1
EP300 0 1 0 0 0 1
NPC1 0 0 0 0 1 1
PIK3CA 1 0 0 0 0 1
TET2 0 1 0 0 0 1
TP53, WRAP53 1 0 0 0 0 1

Submitter and significance breakdown #

Total submitters: 6
Download table as spreadsheet
Submitter pathogenic likely pathogenic uncertain significance likely benign benign total
Fulgent Genetics, Fulgent Genetics 14 9 19 6 2 50
Institute for Genomic Medicine (IGM) Clinical Laboratory, Nationwide Children's Hospital 3 7 0 0 0 10
Department of Pathology and Laboratory Medicine, Sinai Health System 1 0 1 0 0 2
OMIM 2 0 0 0 0 2
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories 0 0 0 0 1 1
Juno Genomics, Hangzhou Juno Genomics, Inc 1 0 0 0 0 1

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. The submitted information has not been verified. If you have questions about the information contained on this website, please see a health care professional.